ESC Congres 2014 Barcelona


Op het ESC in Barcelona was de groep onderzoekers van CONCOR goed vertegenwoordigd.

Twee sprekers mochten hun project nader toelichten namelijk A.C. van Riel over "Clinical predictors of mortality in adults with right-sided congenital heart disease" en M.A. Sluman met het onderwerp: "Cancer: another threat for adults with congenital heart disease"

Ook werden er 10 posters gepresenteerd met verschillende onderwerpen :

- Longitudinal changes in quality of life predict mortality in adult patients with pulmonary arterial hypertension due to congenital heart disease. ( I.M. Blok)

- The risk of type B aortic dissection in Marfan syndrome ( A.W. Den Hartog)

- Tricuspid regurgitation predicts adverse events in tetralogy of Fallot (J.P. Bokma)

- Right ventricular parameters are superior to clinical events for prognosis of patients with pulmonary hypertension due to chd: long term outcome of a prospective study.( M.J. Schuuring)

- Enhanced beneficial outcome of losartan therapy in Marfan patients with FBN1 haploinsufficiency mutations.( R. Franken)

- Adults with tetralogy of Fallot may have structural brain damage and cognitive impairment

(M.A. Sluman)

- Suppressing inflammation in Marfan syndrome: be careful (R. Franken)

- Congenital heart disease and atrial fibrillation of flutter: the rate of thromboembolism and

- bleeding events. (J.F. Heidendael)

- Outcome after cardiac surgery in adults with congenital –versus acquired heart disease right

- Sided anomalies carry the highest mortality risk. (A.C.M.J. van Riel)

- Graft dysfunction and failure during long-term follow-up after pulmonary valve replacement in

Tetralogy of Fallot (J.P. Bokma)